Cargando…

Novel Therapeutic Targets for Migraine

Migraine, a primary headache disorder involving a dysfunctional trigeminal vascular system, remains a major debilitating neurological condition impacting many patients’ quality of life. Despite the success of multiple new migraine therapies, not all patients achieve significant clinical benefits. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nisar, Areeba, Ahmed, Zubair, Yuan, Hsiangkuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952984/ https://www.ncbi.nlm.nih.gov/pubmed/36831105 http://dx.doi.org/10.3390/biomedicines11020569

Ejemplares similares

Role of Atogepant in the Treatment of Episodic Migraines: Clinical Perspectives and Considerations
por: Cohen, Fred, et al.
Publicado: (2022)

Calcitonin Gene-Related Peptide (CGRP)-Targeted Monoclonal Antibodies and Antagonists in Migraine: Current Evidence and Rationale
por: Cohen, Fred, et al.
Publicado: (2022)

Update of Neuromodulation in Chronic Migraine
por: Yuan, Hsiangkuo, et al.
Publicado: (2021)

The K(ATP) channel in migraine pathophysiology: a novel therapeutic target for migraine
por: Al-Karagholi, Mohammad Al-Mahdi, et al.
Publicado: (2017)

Efficacy and Tolerability of STOPAIN for a Migraine Attack
por: St. Cyr, Andrea, et al.
Publicado: (2015)

Targeting TRP Channels For Novel Migraine Therapeutics
por: Dussor, Gregory, et al.
Publicado: (2014)

Exploring Novel Therapeutic Targets in the Common Pathogenic Factors in Migraine and Neuropathic Pain
por: Tajti, János, et al.
Publicado: (2023)

Migraine: Experimental Models and Novel Therapeutic Approaches
por: Tardiolo, Giuseppe, et al.
Publicado: (2019)

Aquaporin 1, a potential therapeutic target for migraine with aura
por: Xu, Guang-Yin, et al.
Publicado: (2010)

Exploring the effectiveness of artificial intelligence, machine learning and deep learning in trauma triage: A systematic review and meta-analysis
por: Adebayo, Oluwasemilore, et al.
Publicado: (2023)

Matrix Metalloproteinases in Neuropathic Pain and Migraine: Friends, Enemies, and Therapeutic Targets
por: Lakhan, Shaheen E., et al.
Publicado: (2012)

TRP Channels: Recent Development in Translational Research and Potential Therapeutic Targets in Migraine
por: Spekker, Eleonóra, et al.
Publicado: (2022)

Digital Therapeutics in Migraine Management: A Novel Treatment Option in the COVID-19 Era
por: Chen, Xingchen, et al.
Publicado: (2023)

New Insights on Metabolic and Genetic Basis of Migraine: Novel Impact on Management and Therapeutical Approach
por: Simonetta, Irene, et al.
Publicado: (2022)

The Pediatric Trochlear Migraine: Diagnostic and Therapeutic Implications
por: Raieli, Vincenzo, et al.
Publicado: (2022)

Targeted Orexin and Hypothalamic Neuropeptides for Migraine
por: Strother, Lauren C., et al.
Publicado: (2018)

Understanding the Mechanism of Hepatic Fibrosis and Potential Therapeutic Approaches
por: Ahmad, Areeba, et al.
Publicado: (2012)

LINGO-1 and AMIGO3, potential therapeutic targets for neurological and dysmyelinating disorders?
por: Foale, Simon, et al.
Publicado: (2017)

Neurodegenerative Diseases: Regenerative Mechanisms and Novel Therapeutic Approaches
por: Hussain, Rashad, et al.
Publicado: (2018)

Future targets for migraine treatment beyond CGRP
por: Al-Hassany, Linda, et al.
Publicado: (2023)

Prolactin and oxytocin: potential targets for migraine treatment
por: Szewczyk, Anna K., et al.
Publicado: (2023)

Migraine Treatment: Towards New Pharmacological Targets
por: Silvestro, Marcello, et al.
Publicado: (2023)

Overview on Common Genes Involved in the Onset of Glioma and on the Role of Migraine as Risk Factor: Predictive Biomarkers or Therapeutic Targets?
por: Casili, Giovanna, et al.
Publicado: (2022)

Emerging therapeutic options for acute migraine: focus on the potential of lasmiditan
por: Rizzoli, Paul B
Publicado: (2014)

TRP Channels and Migraine: Recent Developments and New Therapeutic Opportunities
por: Benemei, Silvia, et al.
Publicado: (2019)

Therapeutic novelties in migraine: new drugs, new hope?
por: Do, Thien Phu, et al.
Publicado: (2019)

The Role of DLLs in Cancer: A Novel Therapeutic Target
por: Xiu, Meng-Xi, et al.
Publicado: (2020)

Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP
por: Yuan, Yuan, et al.
Publicado: (2011)

Topiramate: the evidence for its therapeutic value in the prevention of migraine
por: Nadin, Carole
Publicado: (2005)

Targeted 5-HT(1F) Therapies for Migraine
por: Vila-Pueyo, Marta
Publicado: (2018)

Targeted Acid-Sensing Ion Channel Therapies for Migraine
por: Karsan, Nazia, et al.
Publicado: (2018)

ATP-Sensitive Potassium Channels in Migraine: Translational Findings and Therapeutic Potential
por: Clement, Amalie, et al.
Publicado: (2022)

Targeting Peripheral N-Methyl-D-Aspartate Receptor (NMDAR): A Novel Strategy for the Treatment of Migraine
por: Kalatharan, Veberka, et al.
Publicado: (2023)

EZH2: novel therapeutic target for human cancer
por: Li, Long-Yuan
Publicado: (2014)

Novel hypotheses emerging from GWAS in migraine?
por: van den Maagdenberg, Arn M. J. M., et al.
Publicado: (2019)

Epilepsy: Novel therapeutic targets
por: Anovadiya, Ashish P., et al.
Publicado: (2012)

Novel Biomarkers and Therapeutic Targets for Melanoma
por: Sabag, Noa, et al.
Publicado: (2022)

Renin angiotensin system: A novel target for migraine prophylaxis
por: Nandha, Ruchika, et al.
Publicado: (2012)

Care Gaps and Recommendations in Vestibular Migraine: An Expert Panel Summit
por: Mallampalli, Monica P., et al.
Publicado: (2022)

Serotonin receptor agonists in the acute treatment of migraine: a review on their therapeutic potential
por: Negro, Andrea, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_deov0og89qp5m4to6sucu405jc